
KRM22 announces addition of exchange data news service to GRP
KRM22 has announced the addition of an Exchange Data News Service to its Global Risk Platform. Our new service will allow risk professionals access to analyse and discern same day
KRM22 has announced the addition of an Exchange Data News Service to its Global Risk Platform. Our new service will allow risk professionals access to analyse and discern same day
The CME’s SPAN 2 margin methodology is going through testing and should begin to be implemented later this year. The new margin methodology is not only a significant change to
Most financial services firms have qualified internal technology resources and market knowledge and as a result they have a genuine choice between licensing products from independent software vendors (ISV) to
I will admit it, I spend far too much time on social media. My use of social media has extended from keeping up with family and friends across the globe, to
An RCSA is undertaken by ‘the business’ (first line of defence) with support and oversight from the risk management function (second line of defence). The quality and integrity of the
Holy Cow! Over the past 15 months we have seen remarkable events in the medical field, in nature, politics, sports and the trading markets. The headliners include Covid-19, vaccine development,
There is a well-established business adage, “you can not manage, what you can not measure”. Within the KRM22 Enterprise Risk Cockpit, Metrics are the primary item type for measurement. Metrics
The question I often hear debated, what is the biggest issue that businesses face in the capital markets? Regulation? Cost? Low interest rates? Return on Capital, legacy systems infrastructure or
Since Nikhil Rathi’s arrival last October as CEO of the FCA, he has been busy transforming the FCA towards a “data driven” culture. A key part of the transformation was
Holy Cow! Over the past 15 months we have seen remarkable events in the medical field, in nature, politics, sports and the trading markets. The headliners include Covid-19, vaccine development,